|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002045,
umls-concept:C0017431,
umls-concept:C0026882,
umls-concept:C0031437,
umls-concept:C0205314,
umls-concept:C0449774,
umls-concept:C0674432,
umls-concept:C0679622,
umls-concept:C0754188,
umls-concept:C1272745,
umls-concept:C1707520
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2003-4-17
|
|
pubmed:abstractText |
Current genotypic algorithms suggest that the HIV-1 protease inhibitors (PI) lopinavir (LPV) and amprenavir (APV) have distinct resistance profiles. However, phenotypic data indicate that cross-resistance is more common than expected.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
2
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
955-61
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12700444-Algorithms,
pubmed-meshheading:12700444-Carbamates,
pubmed-meshheading:12700444-Drug Resistance, Viral,
pubmed-meshheading:12700444-Genotype,
pubmed-meshheading:12700444-HIV Infections,
pubmed-meshheading:12700444-HIV Protease,
pubmed-meshheading:12700444-HIV Protease Inhibitors,
pubmed-meshheading:12700444-HIV-1,
pubmed-meshheading:12700444-Humans,
pubmed-meshheading:12700444-Lopinavir,
pubmed-meshheading:12700444-Mutation,
pubmed-meshheading:12700444-Phenotype,
pubmed-meshheading:12700444-Pyrimidinones,
pubmed-meshheading:12700444-Sulfonamides
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistance.
|
|
pubmed:affiliation |
ViroLogic, South San Francisco, California, USA.
|
|
pubmed:publicationType |
Journal Article
|
